Takekai International, a professional asset management firm that offers comprehensive investment management capabilities that span across all main segments of the global capital markets, continually enhancing its existing platforms and value-creation expertise through innovation and refinement of technologies, today announced that the firm’s Board of Executives have reached a consensus regarding the designation of a Managing Director for the newly enhanced Alternative Investments department. Out of a short list of only four names, Mr. Pavel Hajek came out on top, securing the department’s Head position.
Takekai International, a company dedicated to outperforming its competitors through client satisfaction and innovative market approach, has recently enhanced the Alternative Investment team, adding personnel and widening the departments hierarchic structure, creating a top-to-bottom division of experts in the field of alternative investments such as private equity, hedge funds, commodities and tangible assets, among others.
The alternative Investment Division currently overarches a 23 staff-member team, with six expert traders, seven experienced researchers and market analysts, four management roles and other technical and administrative personnel. The primary market of focus will remain the local Asian markets, however, the newly enhanced capabilities of the department are expected to increase the non-Asian alternative investment projects by 30% in the next 5 years.
“I have over 23 years of experience with non-conventional investment management and in my latest endeavour I have occupied the Executive position for the Risk Assessment Division in one of the biggest investment banks in Asia. I would say my biggest advantage is my risk anticipation calculus and my increased accuracy of short- to medium-term market projections. Together with the methodology and skills of Takekai International Alternative Investments Division’s team we can over exceed client expectation. This is our goal and priority, our clients”, declared Mr. Hajek.
Takekai International Alternative Investments Division is already fully operational and has a profit return target imposed by the Executive Board of 15% to 17% in the first year of trading. The department also represents a business expansion opportunity as the Board of Directors might be inclined to relocate it to an international location within South East Asia.
About Takekai International
Takekai International offers comprehensive investment management capabilities that span all segments of the global capital markets. The firm’s investment solutions, tailored to the unique return and risk objectives of institutional clients in more than 40 countries, draw on a robust body of proprietary research and a collaborative culture that encourages independent thought and healthy debate. Customers are the reason the firm exists and are at the heart of everything Takekai International does. That is why we seek to provide superior investment results, exceptional service, and multiple layers of risk management.
Contact Pavel Hajek - +81-905-5567-185
KISSPR PR NEWS DISCLAIMER##
This news has been published for the above source. If you purchase any items using the product and services mentioned in the link, read and accept the terms at your own risk. — Content creator did not involve the KISS PR news desk in the creation or image in this content. — KISS PR, and its distribution partners are not directly or indirectly responsible for any claims made in the above statements. — Contact the vendor of the product directly. — KISS PR or its distribution partners are not responsible for news ranking or SEO of news and its rankings. Ultimately it is always a final decision of distribution partners, and how it indexes on search engines and distribution sites. — KISS PR, or its distribution partners have no control / cannot change any ranks factors. Story.KissPR.com
The above review statements are those of the sponsor (Source of content) and do not necessarily reflect the official policy, position or views of the content publisher. The content distribution company is therefore not responsible for the content and its authenticity and legal standing of the above subject matter. Each individual is required to exercise its content when making a purchase from the above offer. The information does not constitute advice or an offer to buy. Any purchase made from the above press release is made at your own risk. Editorial merit of this content is subject to news publisher and its downstream partners. Consult an expert advisor/health and professional advisor before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website's selling as mentioned in the above as source. The content publisher and its downstream distribution partners do not take any responsibility directly or indirectly. If you have any complaints or copyright issues related to this article, kindly contact the company this news is about.
DISCLAIMER of Liability. IN NO EVENT SHALL OUR PR COMPANY BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OR OF THE ACCURACY, RELIABILITY, OR LEGALITY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY advertisement, sponsorship, endorsement, testimonial, opinion, or other product-related or service-related statement or review appearing in the Websites or in ANY post or article distributed via the Websites.
Release ID: 15282